Skip to Content

What is the difference between Briviact and Keppra?

Answers (1)

Official Answer by Drugs.com 5 May 2016

Briviact (generic name brivaracetam) from UCB is an anti-seizure medication and was FDA-approved in February 2016. Both Briviact and Keppra (generic name levetiracetam) are used in epilepsy.

Briviact is an analogue of Keppra and used with other seizure medications in the treatment of partial-onset seizures in patients 16 years of age and older with epilepsy. Keppra is also used to treat partial onset seizures in adults and children at a younger age.

Both drugs target the synaptic vesicle protein 2A, but the newer agent Briviact is noted to be more selective and have higher affinity for this receptor than Keppra. Keppra is also used to treat tonic-clonic seizures in adults and children who are at least 6 years old, and myoclonic seizures in adults and children who are at least 12 years old.

Briviact is available in oral tablets, oral solution and in an intravenous (IV) injection. Keppra comes as regular-release or extended-release oral tablets (Keppra XR), as an oral solution, or as an IV injection.

An orally-dissolving tablet form of levetiracetam known as Spritam is also available for patients 4 years and older.

Votes: +0
Drugs.com free discount card

Further Information

Search for questions

Still looking for answers? Try searching for what you seek or ask your own question.

Frequently Asked Questions

How is Lartruvo administered?

Posted 9 days ago 1 answerFAQ by Drugs.com

How do you calculate the dosage for Carnexiv?

Posted 9 days ago 1 answerFAQ by Drugs.com

How does Yosprala work?

Posted 9 days ago 1 answerFAQ by Drugs.com

How is Cuvitru administered?

Posted 9 days ago 1 answerFAQ by Drugs.com

How is Troxyca ER formulated to be abuse deterrent?

Posted 9 days ago 1 answerFAQ by Drugs.com